Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
Nayeong Koo, Arun Sharma, Satya Narayan
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5005-5005
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53
Yongmi Huang, Zhihao Jiao, Yuqing Fu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116121-116121
Closed Access | Times Cited: 15
Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 60
De novo molecular design with deep molecular generative models for PPI inhibitors
Jianmin Wang, Yanyi Chu, Jiashun Mao, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 48
The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer
Bryce Wallis, Katherine E. Redd Bowman, Phong Lu, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 159-159
Open Access | Times Cited: 33
Explore drug-like space with deep generative models
Jianmin Wang, Jiashun Mao, Meng Wang, et al.
Methods (2023) Vol. 210, pp. 52-59
Closed Access | Times Cited: 22
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Youyi Huang, Xiaofang Che, Peter Wang, et al.
Seminars in Cancer Biology (2024) Vol. 101, pp. 44-57
Closed Access | Times Cited: 11
TP53 to mediate immune escape in tumor microenvironment: an overview of the research progress
Kaili Zhu, Fei Su, Jingru Yang, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 9
Engineered MSC‐sEVs as a Versatile Nanoplatform for Enhanced Osteoarthritis Treatment via Targeted Elimination of Senescent Chondrocytes and Maintenance of Cartilage Matrix Metabolic Homeostasis
Kai Feng, Jiashuo Liu, Liangzhi Gong, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
p53 and Myofibroblast Apoptosis in Organ Fibrosis
Kealan McElhinney, Mustapha Irnaten, Colm O’Brien
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6737-6737
Open Access | Times Cited: 17
MDMX in Cancer: A Partner of p53 and a p53-Independent Effector
Lin Wu, Yuxiang Yan, Qingling Huang, et al.
Biologics (2024) Vol. Volume 18, pp. 61-78
Open Access | Times Cited: 7
The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence
Bashar A. Alhasan, А. В. Морозов, Irina V. Guzhova, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189119-189119
Closed Access | Times Cited: 6
MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
André T. S. Vicente, Jorge A. R. Salvador
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11068-11068
Open Access | Times Cited: 26
p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
Chahat, Rohit Bhatia, Bhupinder Kumar
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115020-115020
Closed Access | Times Cited: 24
MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation
Karolina Pellot, Julian S. Rechberger, Leo F. Nonnenbroich, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1879-1879
Open Access | Times Cited: 15
C3-Spirooxindoles: Divergent chemical synthesis and bioactivities (2018–2023)
Mohamed H. Helal, Medhat E. Owda, Amal T. Mogharbel, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107091-107091
Closed Access | Times Cited: 5
TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds
Rituraj Chakraborty, Anupam Dutta, Rupak Mukhopadhyay
Clinical & Translational Oncology (2025)
Closed Access
Computational insights into Sitahe (Leuconotis eugenifolia) bioactive compounds: A promising approach for radioprotection through p53 inhibition
Dian Pribadi Perkasa, Iin Kurnia, Taufik Muhammad Fakih, et al.
Pharmacia (2025) Vol. 72, pp. 1-14
Open Access
Designer polyQ fusion proteins sequester USP7/HDM2 for modulating P53 functionality
Xiangle Zhang, Hongwei Yue, Yajun Liu, et al.
iScience (2025) Vol. 28, Iss. 3, pp. 112025-112025
Open Access
Mechanisms and molecular characterization of relapsed/refractory neuroblastomas
Chong Chen, Zixuan Wei
Frontiers in Oncology (2025) Vol. 15
Open Access
The expression of liver–gonadal axis genes reveals the long–term effects of exogenous estradiol on gonad development and liver function in GIFT tilapia
Ye Yuan, Zexun Zhou, Sheng Chen, et al.
Reproduction and Breeding (2025) Vol. 5, Iss. 2, pp. 11-20
Closed Access
Binding Free Energy Analysis of Colicin D, E3 and E8 to Their Respective Cognate Immunity Proteins Using Computational Simulations
Mahesh Koirala, Clifton K. Fagerquist
Molecules (2025) Vol. 30, Iss. 6, pp. 1277-1277
Open Access
Expression of PSMD2 gene in hepatocellular carcinoma and its correlation with immune checkpoints and prognosis
Gu MeiYing, Wanlong Ma, Zi-min Ma, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Functions and mechanisms of non-histone post-translational modifications in cancer progression
Zongyang Li, Tao Zhu, Yushu Wu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Voltage-gated sodium channels: from roles and mechanisms in the metastatic cell behavior to clinical potential as therapeutic targets
Ana Laura Sánchez-Sandoval, Everardo Hernández‐Plata, Juan Carlos Gómora
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning
Wanchun Yang, Jian Wang, Lu Zhao, et al.
Molecules (2024) Vol. 29, Iss. 14, pp. 3377-3377
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top